137 related articles for article (PubMed ID: 3750245)
21. Selecting appropriate therapy for bronchial carcinoma.
Shields TW
Geriatrics; 1974 Jul; 29(7):54-60. PubMed ID: 4835739
[No Abstract] [Full Text] [Related]
22. [Therapy of small-cell bronchial carcinoma].
Bodemann HH; Arnold H; Wannenmacher M; Kraft A
Dtsch Med Wochenschr; 1984 Jun; 109(23):913-5. PubMed ID: 6086263
[No Abstract] [Full Text] [Related]
23. The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison.
Shorthouse AJ; Peckham MJ; Smyth JF; Steel GG
Br J Cancer Suppl; 1980 Apr; 4():142-5. PubMed ID: 6252930
[TBL] [Abstract][Full Text] [Related]
24. Methods of immunosuppression for study of growth and lung colony formation by human tumor cells in mice.
Kovnat A; Khoo K; Selby P; Tannock I
Cancer Res; 1986 Apr; 46(4 Pt 1):1617-22. PubMed ID: 3512076
[TBL] [Abstract][Full Text] [Related]
25. [After care of operated bronchogenic carcinoma with an atoxic antineoplastic agent].
Hansen JL
Ugeskr Laeger; 1975 Jun; 137(26):1466-9. PubMed ID: 1096394
[No Abstract] [Full Text] [Related]
26. Bronchogenic carcinoma: results of surgery plus RSV or without RSV.
Hansen JL
Bronches; 1974; 24(4):206-8. PubMed ID: 4429828
[No Abstract] [Full Text] [Related]
27. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma.
Hansen JL
Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327
[No Abstract] [Full Text] [Related]
28. [Spirazidin in the complex treatment of lung cancer].
Shkrob OS; Zharikov AA
Khirurgiia (Mosk); 1970 Aug; 46(8):17-22. PubMed ID: 5473666
[No Abstract] [Full Text] [Related]
29. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.
Abe T; Tada M; Shinohara N; Okada F; Itoh T; Hamada J; Harabayashi T; Chen Q; Moriuchi T; Nonomura K
Int J Urol; 2006 Jan; 13(1):47-57. PubMed ID: 16448432
[TBL] [Abstract][Full Text] [Related]
30. The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice.
Sheard CE; Double JA; Berenbaum MC
Br J Cancer; 1971 Dec; 25(4):838-44. PubMed ID: 5144544
[TBL] [Abstract][Full Text] [Related]
31. Comparative functional histopathology of human breast carcinoma xenografts.
Bailey MJ; Ormerod MG; Imrie SF; Humphreys J; Roberts JD; Gazet JC; Neville AM
Br J Cancer; 1981 Feb; 43(2):125-34. PubMed ID: 7470377
[TBL] [Abstract][Full Text] [Related]
32. Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.
Selby PJ; Courtenay VD; McElwain TJ; Peckham MJ; Steel GG
Br J Cancer; 1980 Sep; 42(3):438-47. PubMed ID: 7426346
[TBL] [Abstract][Full Text] [Related]
33. [Kinetics of development of human melanoma xenografts in immunosuppressed animals].
Ostrovskaia LA; Ul'ianova NM; Fomina MM; Rykova VA; Konradov AA; Brin EF; Gorbunova NV; Gorbacheva LB; Khaleev DV
Izv Akad Nauk Ser Biol; 1998; (1):5-13. PubMed ID: 9542331
[TBL] [Abstract][Full Text] [Related]
34. A randomized study comparing irradiation alone to irradiation plus procarbazine in inoperable bronchogenic carcinoma.
Landgren RC; Hussey DH; Samuels ML; Leary WV
Radiology; 1973 Aug; 108(2):403-6. PubMed ID: 4578183
[No Abstract] [Full Text] [Related]
35. Chemotherapy of human tumors in T-lymphocyte-deficient mice.
Mitchley BC; Clarke SA; Connors TA; Carter SM; Neville AM
Cancer Treat Rep; 1977; 61(3):451-62. PubMed ID: 406045
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic response of three human tumor lines maintained in immune-suppressed mice.
Kopper L; Steel GG
Cancer Res; 1975 Oct; 35(10):2704-13. PubMed ID: 1157045
[TBL] [Abstract][Full Text] [Related]
37. Nude mouse xenografts as in vivo models for lung carcinomas.
Bepler G; Neumann K
In Vivo; 1990; 4(5):309-15. PubMed ID: 1966790
[TBL] [Abstract][Full Text] [Related]
38. [Implantation of human bronchial cancers in the thymus-aplastic nude mouse for the development of tumor models].
Schuchhardt CH; Haas HJ; Fiebig HH; Henss H; Löhr GW; Wolfart W; Kaiser D; Koch H
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():1009-10. PubMed ID: 6647240
[No Abstract] [Full Text] [Related]
39. Small-cell bronchogenic carcinoma; advances in treatment.
Bergevin PR
N Y State J Med; 1980 Nov; 80(12):1847-50. PubMed ID: 6262689
[No Abstract] [Full Text] [Related]
40. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
González Aragoneses F
Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
